Category: Covid-19

Page 463«..1020..462463464465..470480..»

COVID-19 in South Dakota: 904 total new cases; Death toll at 2,294; Active cases at 6,534 – KELOLAND.com

November 16, 2021

SIOUX FALLS, S.D. (KELO) There were five new COVID-19 deaths reported in Tuesdays update from the South Dakota Department of Health, bringing the total to 2,294, up from 2,289 on Monday.

The new deaths include two women and three men in the following age ranges: 50-59 (3); 70-79 (1); 80+(1). New deaths were reported in the following counties: Codington, Jackson, Minnehaha, Tripp and Walworth.

Numbers in the Tuesday update are from Saturday at 1 p.m. Monday at 1p.m., according to Secretary of Health Kim Malsam-Rysdon.

There were 904 new total COVID-19 cases reported on Tuesday bringing the states total case count to 160,992, up from Monday (160,088).

The number of active cases reported on Tuesday is at 6,534, down from Monday (6,535).

Current hospitalizations are at 236, down from Monday (243). Total hospitalizations are at 8,188, up from 8,129 on Monday.

Total recovered cases are now at 152,164, up from Monday (151,264).

The DOH currently reports total tests each day. There have been 1,664,635, total tests reported as of Tuesday, up 6,245 from 1,658,390 total tests reported Monday.

The latest seven-day PCR test positivity rate for the state is 15.5% for Nov. 8 14.

Of South Dakotas 66 counties, 63 are listed as having high or substantial community spread. High community spread is 100 cases or greater per 100,000 or a 10% or greater PCR test positivity rate.

There have been 791 Delta variant cases (B.1.617.2, AY.1-AY.25) detected in South Dakota through sentinel monitoring, an increase of 16 over the previous report.

There have been 172 cases of the B.1.1.7 (Alpha variant), 3 cases of P.1. (Gamma variant) and 2 cases of the B.1.351 (Beta variant).

The DOH announced changes to how it reports vaccinations on the COVID-19 dashboard as of Monday, October 14. It now includes a breakout of how many people have received booster doses. Due to data clean-up efforts, the percentages of people whove received one dose or completed the series have changed. Findthe DOH explanation in this story.

As of Tuesday, 69.76% the population 12-years-old and above has received at least one dose while 58.79% have completed the vaccination series. 13.09% of those eligible have completed their booster dose.

There have been 534,110 doses of the Pfizer vaccine administered, 382,975 of the Moderna vaccine and 38,326 doses of the Janssen vaccine.

There have been 164,793 persons who have completed two doses of Moderna. There have been 226,174 persons who have received two doses of Pfizer.

As for booster doses, 57,862 people have received a 3rd Pfizer shot, 36,047 have received a 3rd Moderna dose and 914 have received a Janssen booster.

The state is also reporting updated numbers for the number of children under 12 years of age who have received a vaccine. It shows 5,938 have gotten the vaccine, which is 4.05% of that population.

View original post here:

COVID-19 in South Dakota: 904 total new cases; Death toll at 2,294; Active cases at 6,534 - KELOLAND.com

Heres how close Rhode Island is to being vaccinated against COVID-19 – WPRI.com

November 16, 2021

by: Alix Martichoux, Nexstar Media Wire

(NEXSTAR) In December, it will be one year since the first COVID vaccine was administered in the U.S. Its time to do a progress report.

While many health experts are moving away from the idea of herd immunity, vaccinating against COVID-19 is still the best way to protect people from the virus, they say especially when it comes to serious and deadly cases. How well are we doing at vaccinating people?

Below is the percentage of each states population that is fully vaccinated against COVID-19.

The states with the highest percentage of fully vaccinated people are some of the smallest, including Rhode Island, Connecticut, and Vermont. States in the rural West and the South have some of the lowest vaccination rates. West Virginia has the lowest rate of all 50 states, with just 41% of its population fully vaccinated.

A person is considered fully vaccinated when they receive two doses of the Moderna or Pfizer vaccine, or one dose of Johnson & Johnson.

Alabama: 46%Alaska: 54%Arizona: 54%Arkansas: 49%California: 62%Colorado: 63%Connecticut: 71%Delaware: 61%Florida: 61%Georgia: 49%Hawaii: 60%Idaho: 45%Illinois: 62%Indiana: 50%Iowa: 56%Kansas: 54%Kentucky: 52%Louisiana: 48%Maine: 72%Maryland: 67%Massachusetts: 70%Michigan: 54%Minnesota: 62%Mississippi: 46%Missouri: 50%Montana: 51%Nebraska: 57%Nevada: 54%New Hampshire: 64%New Jersey: 67%New Mexico: 63%New York: 68%North Carolina: 54%North Dakota: 48%Ohio: 53%Oklahoma: 51%Oregon: 64%Pennsylvania: 62%Rhode Island: 72%South Carolina: 51%South Dakota: 54%Tennessee: 49%Texas: 54%Utah: 55%Vermont: 72%Virginia: 64%Washington: 64%West Virginia: 41%Wisconsin: 59%Wyoming: 45%

The vaccination rates above are from the New York Times COVID-19 tracking project using data from the Centers for Disease Control and Prevention. We rounded each number to the nearest percentage point.

Note that even if everyone who is eligible to receive a vaccine did so, the numbers in every state still wouldnt be 100%. Thats because there is no coronavirus vaccine approved for children under 5 years old, so they cant be vaccinated yet. The U.S. Census Bureau estimates about 6% of people in the country are under 5.

With the Pfizer vaccines emergency use authorization just recently expanding to children ages 5 to 11, we may see some jumps in states vaccination rates in the coming weeks.

Link:

Heres how close Rhode Island is to being vaccinated against COVID-19 - WPRI.com

Do you need a COVID-19 booster shot? – University of Georgia

November 16, 2021

Lower antibody level doesn't mean less protection from the coronavirus

If you got the COVID-19 shots back in early spring, your antibodies are likely waning. But its not something you need to be worried about, according to a new study from the University of Georgia.

Overall, antibody levels are decreasing, but their ability to protect against infection isnt, said Ted Ross, lead author and the director of UGAs Center for Vaccines and Immunology. The quality is still there even if the total quantity has gone down.

Published in Frontiers in Immunologys Vaccines and Molecular Therapeutics, the study found that vaccination results in a significantly more robust immune response than seen in people who contracted the coronavirus naturally.

The takeaway is that even if you have waning antibodies, the quality of those antibodies still protects you against severe disease and hospitalization. Ted Ross, Center for Vaccines and Immunology

Vaccinated participants showed higher levels of neutralizing antibodies, which serve as lookouts for viruses and alert the bodys immune system when its been infected. These individuals antibodies were also more effective at binding with the virus, which prevents it from latching onto and infecting cells.

Additionally, the study showed that for most people who were infected with the virus, a single shot of the Moderna or Pfizer vaccine was enough to make them fully immune to the coronavirus. Some may require both shots to be fully protected, though, and theres currently no way to tell who does or doesnt. So, Ross recommends that everyoneeven those whove had COVID-19receive the second shot. It doesnt hurt you to get the second one, he said.

Ted Ross, the director of UGAs Center for Vaccines and Immunology, found that COVID-19 antibody quality is more important than quantity. (Photo by Peter Frey/UGA)

The research is part of a large-scale, multi-year surveillance program with more than 3,100 participants, ranging from 18 to 90 years old. They give blood and saliva samples each month so the researchers can track their immune response to vaccination or natural infection.

The takeaway is that even if you have waning antibodies, the quality of those antibodies still protects you against severe disease and hospitalization, said Ross, who is also a professor in UGAs College of Veterinary Medicine. People were concerned that if you had waning antibody levels, you would become susceptible to the virus again. But right now that doesnt seem to be the case for most people.

The CDC recently recommended booster shots for older adults, those with underlying medical conditions and people who work or live in high-risk settings if they received the Moderna or Pfizer vaccine series six or more months ago. The agency also encourages a booster for everyone who received the one-shot Johnson & Johnson/Janssen COVID-19 vaccine.

Some health care experts questioned whether booster access should be expanded to all due to the uncertainty surrounding the vaccines long-term efficacy in staving off disease.

But people who were vaccinated in the spring and dont qualify for a booster shouldnt panic.

Now I dont know what will happen in another six months or another 12 months, but right now, if you were vaccinated in the spring, you should still have protective antibodies in you, Ross said. The elderly tend to lose their immunity more quickly. We see that with influenza too. Thats why they have to get vaccinated again. Younger people can maintain it longer.

Department of Public Health nurse Tricia Ellis gives a COVID-19 vaccine to undergraduate Zarae Allen at a pop-up vaccine clinic at the Tate Student Center. (Photo by Andrew Davis Tucker/UGA)

That being said, if youre eligible for a booster, go for it.

My attitude is that if youre offered one, you should get one. It cant hurt you, Ross said. And unfortunately, here in the U.S., many of the vaccines are being thrown away because they reached their expiration date. Its unfortunate that were not shipping them around the world to other people who need them, but if the alternative is throwing them away, I say get a booster shot.

In addition to getting the COVID-19 vaccine series, social distancing and wearing masks are still one of the most important ways to stop the spread of the disease.

This study was funded in part by the National Institute of Allergy and Infectious Diseases. Co-authors include David Forgacs, Hyesun Jang, Rodrigo Abreu, Hannah Hanley, Jasper Gattiker and Alexandria Jefferson, all from UGAs Center for Vaccines and Immunology.

View original post here:

Do you need a COVID-19 booster shot? - University of Georgia

8 deaths reported after recent Covid-19 outbreak at a Connecticut nursing home – CNN

November 16, 2021

A total of 89 residents and staff -- many of whom were fully vaccinated -- have tested positive for Covid-19 in the last seven weeks, Geer Village Senior Community in North Canaan said Friday, and 11 residents and one staff member remain in isolation.

"Sadly, we have lost 8 residents with serious underlying health issues to Covid," the statement said.

CNN has reach out to Geer Village for further comment.

"Geer Nursing residents and staff will be eligible for the booster when we have gone two full weeks with no new positive cases," the nursing home said in their statement. All staff and residents are also subject to bi-weekly testing for Covid-19, and all visits to the center remain on hold until further notice.

"While we must continue with Covid-19 prevention protocols, we want to assure everyone we are doing our best to keep residents and staff safe," the statement said. "We continue to monitor the situation closely and will provide updates for residents, staff, families, and community stakeholders as the situation changes."

Only 10 of the 209 nursing homes and assisted living facilities in Connecticut, or 5%, have active Covid-19 cases, according to the most recent state data from October 27 through November 9. Of those 10 facilities, five facilities have only one active case.

By comparison, 20 of the 209 facilities, or 9.5%, had at least one Covid-19 case from September 15 through September 28, according to state data.

Read the original here:

8 deaths reported after recent Covid-19 outbreak at a Connecticut nursing home - CNN

Gov. Holcomb willing to lift COVID-19 public health emergency if lawmakers agree to 3 things – WTHR

November 16, 2021

The executive orders have included a mask mandate, school guidance and other restrictions that were deemed necessary throughout the pandemic.

INDIANAPOLIS Gov. Eric Holcomb is willing to lift the public health emergency for COVID-19 that has been in place since March 6, 2020. That executive order has been renewed 20 times since it was put into place.

The executive orders have included a mask mandate, school guidance and other restrictions that were deemed necessary throughout the pandemic.

The most recent executive order, signed Oct. 29, noted a decrease in the number of cases of COVID-19 since the September spike, but also pointed to the state seeing more than 1,000 new cases and averaging 17 deaths daily.

The order also points out only 57.3% of eligible Hoosiers are fully vaccinated and that in the week leading up to the order, 830 of 834 new COVID-19 patients admitted to the hospital were unvaccinated, 128 of 135 COVID-19 patients admitted to the ICU were unvaccinated, and 153 of 168 COVID-19 deaths were unvaccinated individuals.

When extending the last state public health emergency for another 30 days, I asked my team to bring me a plan that would allow us to wind it down responsibly. They have presented me a plan that identifies three key items that must be preserved if I am to responsibly allow the state public health emergency to expire," Holcomb said in a statement released Tuesday.

Holcomb said he is working with Indiana Senate President Pro Tempore Rodric Bray (R-Martinsville) and Indiana House Speaker Todd Huston (R-Fishers) on passing three statutory changes. Holcomb said those changes would protect Hoosiers by allowing for the continuation of enhanced federal matching funds for Medicaid expenditures, the continuation of the enhanced benefit for those receiving federal food assistance and extend the ability to efficiently vaccinate our 5- to 11-year-olds.

A spokeswoman for Sen. Bray told 13News that Bray is continuing to "work with the governor and Speaker Huston on a way to end the emergency, but no details have been finalized at this time."

13News reached out to the governor's office for details on what would need to be included in those three areas and is waiting on a response.

Read the original post:

Gov. Holcomb willing to lift COVID-19 public health emergency if lawmakers agree to 3 things - WTHR

Long-term study of children with COVID-19 begins – National Institutes of Health

November 16, 2021

News Release

Monday, November 15, 2021

NIH-supported research will track effects of COVID-19 infection on children over three years.

A large, long-term study of the impacts of COVID-19 on children has enrolled its first participant at the National Institutes of Healths Clinical Center in Bethesda, Maryland. The study, which is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, will track up to 1,000 children and young adults who previously tested positive for COVID-19 and evaluate the impact of COVID-19 on their physical and mental health over three years. The study is expected to yield a detailed picture of COVID-19s effects on the overall health of children, their development and immune responses to infection, and their overall quality of life in the years following infection. This work is part of NIHs Researching COVID to Enhance Recovery (RECOVER) Initiative, to better understand the long-term consequences of SARS-CoV-2 infection.

In the early days of the COVID-19 pandemic, initial data suggested that children were less likely to suffer from severe cases of COVID-19 than older people. However, among the 6 million reported pediatric COVID-19 cases the United States, many children have experienced significant acute and long-term effects of the disease. Although increasing numbers of children are becoming eligible to receive a COVID-19 vaccine, the lack of vaccine-derived protection for most children has made this age group especially vulnerable to infection. In addition, children can suffer from a suite of inflammatory symptoms, collectively called Multisystem Inflammatory Syndrome in Children (MIS-C), that can affect multiple organs and lead to severe illness. MIS-C can arise even when the child initially appeared to be asymptomatic for COVID.

Although we know that children are vulnerable to COVID-19, we still do not have a clear picture of how COVID-19 affects them in the long term, said NIAID Director Anthony S. Fauci, M.D. In adult patients, the long-term sequelae of COVID, including post-acute COVID-19, can significantly affect quality of life. Our investigations into the pediatric population will deepen our understanding of the public health impact that the pandemic has had and will continue to have in the months and years to come.

Study participants will be enrolled with the consent of their parents or guardians. The NIH Clinical Center will recruit children ranging from 3 to 21 years of age, and Childrens National Hospital in Washington, DC, will recruit children ranging in age from birth to 21 years. In addition to tracking the long-term health effects of COVID-19 and attempting to determine risk factors for complications, the study also will evaluate the long-term immune responses to the disease, screen for genetic factors that may affect how children respond to COVID-19 infection, and determine whether immunological factors influence long-term outcomes.

Children may be eligible to be enrolled if they have tested positive for COVID-19 in the past, even if they were asymptomatic. Participants will receive a full physical examination and undergo a complete medical history. Study physicians will collect a variety of baseline samples, including blood, nasal swabs, stool and urine. An optional genetic analysis may be performed to identify potential genetic risk factors for severe COVID-19 outcomes. Participants also will undergo scans of their hearts and other organs. Members of their households without a history of COVID infection also will be asked to enroll as part of a control cohort. In all, the study may enroll up to 2,000 people, the participants who have tested positive for COVID-19 and their household contacts.

Children and young adults who enroll within 12 weeks of a COVID-19 infection or a positive COVID-19 test will visit a clinic for follow-up at three and six months and then every six months for a total of three years. Those who enroll more than 12 weeks after a positive COVID-19 test will have clinic visits scheduled every six months for three years. At these follow-up visits, participants will undergo additional scans, sample analyses, questionnaires, and other means of tracking their health, development, and overall quality of life, including their mental and social well-being. Any re-infections or adverse events that may be linked to a prior COVID-19 infection will be documented. The researchers anticipate that the study will take approximately six years to complete.

For more information about the study, please visit ClinicalTrials.gov using the study identifier NCT04830852.

NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID website.

About the National Institutes of Health (NIH):NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.nih.gov.

NIHTurning Discovery Into Health

###

View original post here:

Long-term study of children with COVID-19 begins - National Institutes of Health

Amazon settles with California over claims it concealed Covid-19 cases from warehouse workers – CNBC

November 16, 2021

Amazon fulfillment center warehouse.

Getty Images

Amazon on Monday reached a settlement with California's attorney general over claims it concealed Covid-19 case numbers from its warehouse workers.

The company has agreed to notify warehouse workers within one day of new Covid cases, as well as provide the exact number of cases in their workplace, California State Attorney General Rob Bonta said in a statement. Amazon employs tens of thousands of warehouse workers in the state, he added.

Under the agreement, which is still subject to court approval, Amazon will also notify local health agencies within 48 hours of new Covid cases and pay $500,000 toward additional enforcement of California consumer protection laws, Bonta said.

Amazon spokesperson Barbara Agrait said there's no change to, nor allegations of any problems with, the company's protocols related to notifying employees who may have been exposed to Covid.

"We're glad to have this resolved and to see that the AG found no substantive issues with the safety measures in our buildings," Agrait said in a statement.

The settlement comes after California in January enacted stricter Covid workplace regulations as part of Assembly Bill 685, or the "right-to-know" law. The regulations require businesses to report Covid cases to workers within one business day, among other stipulations.

Throughout the pandemic, Bonta said Amazon inadequately notified warehouse workers and local health agencies of Covid case numbers, "often leaving them in the dark and unable to effectively track the spread of the virus."

Amazon sends notifications of new Covid cases to warehouse workers via its internal messaging portal, called A to Z, and works to determine if other employees came into contact with the person who tested positive by reviewing on site camera footage, as well as interviewing workers.

Warehouse and delivery workers have previously criticized Amazon's contact tracing and case notification protocols, claiming they're inadequate.

Last year, then-California Attorney General Xavier Becerra opened a probe into Amazon's treatment of warehouse workers during the pandemic.

California's division of the Occupational Safety and Health Administration also fined Amazon last October for coronavirus safety violations at two warehouses in the state. At one site, Amazon didn't notify contracted delivery drivers of confirmed cases, the citation said.

Amazon said at the time that it believed its coronavirus safety measures were "more than adequate."

WATCH: Inside the rapid growth of Amazon Logistics and how it's taking on third-party shipping

See the article here:

Amazon settles with California over claims it concealed Covid-19 cases from warehouse workers - CNBC

Myocarditis, COVID-19 & the Vaccine – Articles and Videos, Cardiac / Heart Health, COVID-19, Featured, Health Topics – Hackensack Meridian Health

November 16, 2021

November 15, 2021

A rare heart condition, myocarditis, may have you wondering, should I get the COVID vaccine? Should I get my child vaccinated?

To help us understand this heart condition and if there is substantial risk from COVID-19 or the vaccine, we connected with cardiologist Brett Sealove, M.D., chief of cardiology at Jersey Shore University Medical Center, and Meghan Tozzi, M.D., a pediatric cardiologist at the Joseph M. Sanzari Childrens Hospital at Hackensack University Medical Center who is part of the Pediatric COVID Recovery Center team.

Myocarditis is the inflammation of the heart muscle and pericarditis is inflammation in the outer lining of the heart; both are typically a response to a viral infection.

Yes, you can get myocarditis from the COVID-19 virus.

In a study from the CDC, patients infected with COVID-19 were 16 times more likely to have myocarditis than patients without COVID-19.

The CDC has reported that heart inflammation is a rare side effect that can occur from the mRNA COVID vaccines, Pfizer or Moderna.

Cases reported have been seen more often in young males, after the second dose and within a few days after vaccination.

We have seen myocarditis in older children and young adults as a result of the vaccine, but even in the highest risk group, 16 to 29 year olds, the risk is one in 40,000, thats .003%, explains Dr. Tozzi.

The risk of getting myocarditis from getting vaccinated is markedly lower than getting myocarditis (or significantly ill) from the COVID virus itself, explains Dr. Sealove. The answer is, you want to prevent COVID infection in your body, including COVID potentially impacting your heart.

For children, the symptoms can be a bit unclear, as it can present in a similar way to things like a cold or other viruses, adds Dr. Tozzi. If your child has COVID-19 or recently received the vaccine, keep an eye on their symptoms and contact their doctor if you have any concerns.

Its usually fairly conservative watch, wait and have them recover on their own. Theres really no great remedy for treatment of myocarditis other than supportive care, explains Dr. Sealove. The vast majority of these cases recover on their own.

It is a rather mild version of myocarditis that develops after vaccination. Children tend to bounce back quickly, get better on their own and return to school in a few days, adds Dr. Tozzi. And again, the risk for myocarditis from the vaccine is very small, and expected to be an even lower risk in the five to 11 year old age group.

I would argue that getting vaccinated and vaccinating your children is the number one priority, rather than concern about a relatively low risk, reversible complication of vaccination, adds Dr. Sealove.

The benefit of being vaccinated, across the spectrum of the ages, appears to far outweigh the risk of myocarditis, concludes Dr. Sealove.

The material provided through HealthU is intended to be used as general information only and should not replace the advice of your physician. Always consult your physician for individual care.

Continued here:

Myocarditis, COVID-19 & the Vaccine - Articles and Videos, Cardiac / Heart Health, COVID-19, Featured, Health Topics - Hackensack Meridian Health

Could COVID-19 end up being worse than the flu year after year? – The San Diego Union-Tribune

November 14, 2021

There is a growing consensus among experts that the coronavirus will likely be with us for many years to come, popping up in pockets even when most people across the globe have immunity through vaccination or natural infection.

Healers, then, should expect to be dealing with some level of ongoing COVID-19 burden once the virus enters what epidemiologists call an endemic state, one in which a pathogen simmers and smolders, producing new cases year after year, but not reaching the heights seen when the level of community immunity was low.

Just how heavy will that burden be?

This story is for subscribers

We offer subscribers exclusive access to our best journalism.Thank you for your support.

In the short term, with global vaccinations still far from universal, most are predicting that another surge this winter is likely. Vaccination, though, is expected to keep things from getting as out of control as they did in late 2020 and early 2021. A new variant capable of dislodging the Delta variant from its current dominance could change that outlook.

This being the first winter without a stay-at-home order, it is already plain to see in weekly reports that San Diego County will have a flu season this year after seeing very little influenza activity in late 2020 and early 2021.

To date, there have been 287 confirmed flu cases reported since July 1, nearly 16 times the 18 reported last season. And this years rate is slightly ahead of the prior five-year average, which includes nearly 12,000 cases per season, and 123 deaths, throughout the county.

Winter, then, will be the first year that the region and the nation feel the full force of the flu and coronavirus simultaneously, and experts fear that its not likely to be the last.

Some highly-educated guesses are already broaching the possibility that the coronavirus could end up producing as many or more cases than the flu.

Its one of three scenarios contemplated by a team of UC San Francisco researchers in a paper published in the journal Nature in July.

One possibility is that the virus will not come under relative control as global immunity builds, leading to a future with ongoing manifestations of severe disease combined with high levels of infection.

Deemed more likely, a second option is that SARS-CoV-2 will enter an endemic state that looks like the flu, which the U.S. Centers for Disease Control and Prevention estimates kills between 12,000 and 52,000 Americans per year.

The virus, researchers noted, could also behave more like other coronaviruses, which tend to have a significantly lower impact than influenza, in an endemic state.

When they published four months ago, the research team was reluctant to pick a scenario among the three, stating that more information was needed.

But, as cases surged, some have begun to feel more comfortable calling their shots.

Much attention has piled up around a series of 17 tweets by Trevor Bedford, the Seattle-based computational virologist recently named a MacArthur Fellow for his work modeling the introduction and spread of novel coronavirus and his advocacy of real-time genetic sequencing as an essential method of helping predict how the pathogen is likely to evolve.

Noting that the novel coronavirus has shown an uncharacteristic ability to mutate, and that there is plenty of evidence of waning immunity among the vaccinated and unvaccinated, Bedford says his best guess is that endemic coronavirus infects between 20 percent and 30 percent of the population each year. Influenza, by comparison, is estimated to infect about 10 percent of the world population per year.

Such a high attack rate, Bedford notes, would produce a larger death rate that could range from 40,000 to 100,000 per year in the U.S.

Most infections would be relatively mild (just like the flu), but theres enough of them that even a small fraction of severe outcomes adds up, Bedford said.

Its a prediction that terrifies public health officials.

Some years, noted Dr. Seema Shah, medical director of San Diego Countys epidemiology division, the flu by itself is capable of swamping emergency departments in the winter. The idea of layering a like number of coronavirus cases on top of that is particularly daunting.

There are some predictions that coronavirus could cause double the number of yearly flu deaths, Shah said. How do we allow that level of risk for that many Americans to die every year?

I find that hard to stomach.

San Diego County is home to plenty of experts in viral evolution, and, while all say that Bedfords scenario is certainly possible, this virus has proven itself enough of a wildcard that certainty is scarce.

I would not be surprised to see SARS-CoV-2 variants continuing to arise, said Joel Wertheim, an evolutionary biologist at UC San Diego whose work traced has traced the early appearance of the the virus in China. That said, every variant, every vaccine, every re-infection, changes the dynamics.

The sands will be constantly shifting, but this virus has no reason to stop trying to evolve more efficient ways to infect and re-infect us.

Kristian Andersen, a microbiologist and immunologist at Scripps Research in La Jolla whose lab has been at the forefront of the worldwide effort to map the mutations appearing in coronavirus as it spreads across the globe, agreed that the flu outcome is very possible but not certain. The focus, he has said repeatedly in recent months, should be on reducing the overall number of new infections. Every time a virus replicates is a chance of a beneficial mutation.

For too long, he said in a recent email, the mark of public health success in the coronavirus fight has been driving down the number of people who get sick enough to need a hospital stay. But driving down infections requires greater levels of vaccination in the meantime and more-rigorous masking and social distancing practices in the short term.

Unfortunately, theres no appetite for that which Im pretty convinced (although not certain) will be a decision well come to regret further down the line, Andersen said. In fact, had we taken this virus seriously from day one, as most experts urged, I dont think wed be talking about alpha, mu, delta, and the rest of them.

Continue reading here:

Could COVID-19 end up being worse than the flu year after year? - The San Diego Union-Tribune

Diabetes is a ‘pandemic of unprecedented magnitude,’ and experts fear Covid-19 may make it worse – CNN

November 14, 2021

Despite a century of advancements in treatment, education and prevention, World Diabetes Day 2021 occurs in the wake of grim statistics. One in 10 adults around the world -- some 537 million people -- are currently living with diabetes, according to figures recently released by the International Diabetes Federation (IDF).

By 2024, the IDF predicted that the number of people with diabetes is expected to rise to 1 in 8 adults.

"As the world marks the centenary of the discovery of insulin, I wish we could say we've stopped the rising tide of diabetes," IDF President Dr. Andrew Boulton told CNN. "Instead, diabetes is currently a pandemic of unprecedented magnitude."

Nearly 7 million adults have died worldwide in 2021 so far due to diabetes or its complications, the IDF estimated -- that's more than 1 in 10 global deaths from any cause.

"And if you want another startling statistic, as many as 40% of the people that have died in the US from Covid-19 had diabetes," said Dr. Robert Gabbay, chief scientific and medical officer for the American Diabetes Association.

The pandemic also took a toll on how well people have managed their diabetes over the past year and a half, said Boulton, who is also a professor of medicine at the University of Manchester in the UK.

"My fear is we're going to see a tsunami in the next two years of diabetes and its complications because people have missed their screening appointments due to fear of catching Covid-19," he said.

Is Covid a trigger for diabetes?

As bad as these numbers are, experts are concerned that Covid-19 might contribute to an even greater problem.

"There may be more people developing diabetes because of Covid," Gabbay told CNN.

Boulton echoed that concern: "There may be a specific Covid-induced diabetes, although there is some debate on that at the moment."

"Whether new-onset diabetes is likely to remain permanent is not known, as the long-term follow-up of these patients is limited," the study reported.

It's very possible that Covid-19 is not the culprit. Blood sugar abnormalities could be triggered by the stress of an infection and the steroids used to fight Covid-19 inflammation, Gabbay said.

People also may have had diabetes that was not previously diagnosed. The IDF estimates that of the 537 million adults living with diabetes around the world, almost half (44.7%) are as yet undiagnosed.

But there is also evidence that SARS-CoV-2, the virus that causes Covid-19, can bind to the ACE2 receptors in the islet cells of the pancreas -- the organ that produces the body's insulin, Boulton and Gabbay told CNN.

"The virus attacks those cells in the pancreas and interferes with their production of insulin, so that may be another mechanism," Gabbay said. "And those individuals that are diagnosed in the hospital with diabetes for the first time, through whichever mechanism, sadly do worse."

Early identification is key

Reversing the rising tide of diabetes cases requires early identification. Nipping Type 2 diabetes in the pre-diabetic stages is preferred, since it's before the body begins to suffer damage from irregular blood sugars and lifestyle changes are easier to implement.

Studies in Finland a few decades ago found that people with "very slight elevated blood sugar" who followed a sensible diet and regular exercise "had a 54% reduction in proceeding to Type 2 diabetes," Boulton said.

"And it didn't have to be flogging yourself in the gym," he added. "It's sensible exercising, walking instead of riding the bus and walking up the stairs instead of taking the elevator, that can do the trick."

Even full-flown diabetes can be put into remission, Gabbay said, with a regime of diet, exercise and stress reduction and proper use of medications.

"People in remission may still be at risk for some of the long-term complications, and therefore, they still need to be monitored, with quarterly blood tests, a yearly eye and foot test, and yearly screening for kidney disease and cholesterol levels," he said.

Being over age 60, overweight, having had gestational diabetes while pregnant, having a family history of diabetes, currently living with high blood pressure and a lack of physical exercise all raise your risk.

Here is the original post:

Diabetes is a 'pandemic of unprecedented magnitude,' and experts fear Covid-19 may make it worse - CNN

Page 463«..1020..462463464465..470480..»